The US Food and Drug Administration (FDA) has granted de novo classification to Onward Medical for its ARC-EX system in patients with spinal cord injury (SCI). The approval marks the first non ...

The ARC-IM Lead delivers targeted electrical pulses to the spinal cord and is a key component of the ONWARD ARC-IM system, an innovative platform engineered to deliver ARC Therapy to address ...

Onward Medical reached its fourth and fifth implantations of the Arc-brain-computer interface therapy implant for patients with spinal cord injuries. The new procedures were completed on a 48-year-old ...

may be converted into a useful result by expressing the position of the centroid in terms of its distance from the chord of the arc and as a fraction of the versine of the arc. Thus the usual form.